Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.
Read More »Common Causes of Death Among Patients with Both Diabetes and ASCVD
Identifying causes of death and related risk factors in patients with type 2 diabetes and cardiovascular disease may help with prevention.
Read More »Greater HbA1c Reduction with DPP4 Inhibitor, AGI Combination
Additive glucose-lowering effect of a dipeptidyl peptidase-4 (DPP4) inhibitor and an alpha-glucosidase inhibitor (AGI) might be beneficial in patients with T2DM.
Read More »Safety and Efficacy of a New Long-Acting Exenatide Formulation: BYDUREON® BCise™
Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.
Read More »Efficacy And Safety When Adding Ertugliflozin to Metformin and Sitagliptin
New SGLT-2 inhibitor can be used as add-on therapy to provide better improvement in HbA1C in patients with type 2 diabetes.
Read More »Real-World Benefits for SGLT-2 Inhibitors
Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.
Read More »Omega-6 Fatty Acid Reduces Risk of Type 2 Diabetes
Study finds linoleic acid has long-term benefits in diabetes prevention, arachidonic acid not harmful.
Read More »Are Statins Related to Diabetes Progression?
Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.
Read More »Semaglutide vs. Semaglutide in Treatment of Diabetes, Obesity
Study compares effectiveness of oral GLP-1 medication over injection.
Read More »Study Assesses Risk of Developing Diabetes, Reversing Prediabetes
Determining which patients benefit most from lifestyle, metformin interventions may improve individualized care decisions.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.